HCW Biologics (HCWB) Insider Trading & Ownership $0.40 0.00 (-0.20%) (As of 05:19 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HCW Biologics (NASDAQ:HCWB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage49.90%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$610,262.28Number OfInsiders Selling(Last 3 Years)0 Get HCWB Insider Trade Alerts Want to know when executives and insiders are buying or selling HCW Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HCWB Insider Buying and Selling by Quarter Ad InvestorPlaceWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning HCW Biologics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/14/2023Hing C WongCEOBuy1,800$2.08$3,744.00 9/13/2023Gary M WinerDirectorBuy546$2.05$1,119.30 9/13/2023Rebecca ByamCFOBuy5,000$2.10$10,500.00 9/11/2023Gary M WinerDirectorBuy99$2.05$202.95 9/11/2023Rebecca ByamCFOBuy5,000$2.05$10,250.00 9/8/2023Rebecca ByamCFOBuy5,000$2.02$10,100.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/7/2023Gary M WinerDirectorBuy63$1.95$122.85 9/6/2023Rebecca ByamCFOBuy5,000$1.95$9,750.00 9/5/2023Gary M WinerDirectorBuy400$1.75$700.00 6/9/2023Rebecca ByamCFOBuy20,000$2.06$41,200.00 6/8/2023Lee FlowersSVPBuy10,000$2.16$21,600.00 6/7/2023Rebecca ByamCFOBuy20,000$2.03$40,600.00 6/5/2023Rebecca ByamCFOBuy20,000$1.67$33,400.00 6/1/2023Hing C WongCEOBuy800$1.62$1,296.00 5/30/2023Gary M WinerDirectorBuy850$1.52$1,292.00 5/30/2023Hing C WongCEOBuy3,000$1.55$4,650.00 5/26/2023Rebecca ByamCFOBuy20,000$1.66$33,200.00 5/24/2023Rebecca ByamCFOBuy20,000$1.61$32,200.00 5/22/2023Rebecca ByamCFOBuy33,450$1.53$51,178.50 9/14/2022Rebecca ByamCFOBuy15,000$2.58$38,700.00 9/12/2022Rebecca ByamCFOBuy15,000$2.65$39,750.00 9/8/2022Hing C WongCEOBuy4,000$2.67$10,680.00 8/29/2022Rebecca ByamCFOBuy10,000$2.57$25,700.00 8/26/2022Rebecca ByamCFOBuy10,000$2.54$25,400.00 8/24/2022Rebecca ByamCFOBuy50,000$2.50$125,000.00 6/13/2022Rebecca ByamCFOBuy7,596$2.08$15,799.68 6/10/2022Gary M WinerDirectorBuy1,500$2.13$3,195.00 6/9/2022Hing C WongCEOBuy2,000$2.25$4,500.00 6/8/2022Gary M WinerDirectorBuy1,000$2.27$2,270.00 6/6/2022Gary M WinerDirectorBuy1,000$2.13$2,130.00 6/2/2022Rick S GreeneDirectorBuy4,800$2.09$10,032.00 (Data available from 1/1/2013 forward) HCWB Insider Trading Activity - Frequently Asked Questions Who is on HCW Biologics's Insider Roster? The list of insiders at HCW Biologics includes Gary M Winer, Hing C Wong, Lee Flowers, Rebecca Byam, and Rick S Greene. Learn more on insiders at HCWB. What percentage of HCW Biologics stock is owned by insiders? 49.90% of HCW Biologics stock is owned by insiders. Learn more on HCWB's insider holdings. Which HCW Biologics insiders have been buying company stock? The following insiders have purchased HCWB shares in the last 24 months: Gary M Winer ($3,437.10), Hing C Wong ($9,690.00), Lee Flowers ($21,600.00), and Rebecca Byam ($272,378.50). How much insider buying is happening at HCW Biologics? Insiders have purchased a total of 171,008 HCWB shares in the last 24 months for a total of $307,105.60 bought. HCW Biologics Key ExecutivesDr. Hing C. Wong Ph.D. (Age 70)Founder, CEO, Director & Secretary Compensation: $421.05kMs. Rebecca Byam CPA (Age 68)M.B.A., Chief Financial Officer Compensation: $297.08kDr. Peter Rhode Ph.D. (Age 66)Chief Scientific Officer & VP of Clinical Operations Compensation: $248.57kMs. Nicole Valdivieso Esq.Vice President of Legal AffairsMs. Raquel Diaz M.S.Director of Human ResourcesMr. Lee D. Flowers (Age 78)Senior Vice President of Business Development More Insider Trading Tools from MarketBeat Related Companies IMMX Insider Ownership VOR Insider Ownership IOBT Insider Ownership ELYM Insider Ownership RPTX Insider Ownership KRON Insider Ownership VNRX Insider Ownership IVVD Insider Ownership MURA Insider Ownership GALT Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:HCWB) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.